• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Holdings
Company Encyclopedia
View More
name
ChinaAMC CSI Biotechnology Theme ETF
516500.SH
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Fosun Pharma Unit's Registration Application for Langerhans Cell Histiocytosis Drug Accepted in China

Fosun Pharma Unit's Registration Application for Langerhans Cell Histiocytosis Drug Accepted in China

marketscreener·1 Hours ago
HK
02196
-3.86%
SH
600196
-1.72%
marketscreener·1 Hours ago
HK
02196
-3.86%
SH
600196
-1.72%

Event Tracking

Nov21
Hengrui Medicine's SHR-1139 Injection Receives Clinical Trial Approval
10:28
Hengrui Medicine Receives Approval Notice for Multiple Drug Clinical Trials
10:28
Fosun Pharma's Lumovemetinib for LCH in Children Receives Priority Review for New Indication
09:28
Nov20
Fosun Pharmaceutical's Subsidiary's Sulrizumab Injection Included in Breakthrough Therapy Program
08:44
Hengrui Medicine Repurchased 209,900 A-shares for 12.7432 Million Yuan
08:38
Nov18
Cao Xiaochun Completes Share Reduction Plan at Theragen Medical
14:15
Terms & Conditions
  • Terms of Service
  • Privacy Policy